Mast Therapeutics, Inc. (NYSE: MSTX) announced that it is joining other industry leaders, patient advocacy groups, researchers, clinicians, policymakers, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE